BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16246405)

  • 21. Prognostic significance of positive peritoneal cytology in adenocarcinoma of the uterine cervix.
    Kasamatsu T; Onda T; Sasajima Y; Kato T; Ikeda S; Ishikawa M; Tsuda H
    Gynecol Oncol; 2009 Dec; 115(3):488-92. PubMed ID: 19767067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study.
    Rotman M; Sedlis A; Piedmonte MR; Bundy B; Lentz SS; Muderspach LI; Zaino RJ
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):169-76. PubMed ID: 16427212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevation of cyclooxygenase-2 is related to lymph node metastasis in adenocarcinoma of uterine cervix.
    Kang S; Kim MH; Park IA; Kim JW; Park NH; Kang D; Yoo KY; Kang SB; Lee HP; Song YS
    Cancer Lett; 2006 Jun; 237(2):305-11. PubMed ID: 16111807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB.
    Bouda J; Boudova L; Hes O; Havir M; Tempfer C; Kohlberger P; Svoboda T; Rokyta Z; Speiser P
    Anticancer Res; 2005; 25(1B):617-22. PubMed ID: 15816636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclooxygenase-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas.
    Baltazar F; Filho AL; Pinheiro C; Moreira MA; Queiroz GS; Oton GJ; Júnior AF; Ribeiro LF; Schmitt FC
    Int J Gynecol Pathol; 2007 Jul; 26(3):235-41. PubMed ID: 17581404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy.
    Irie T; Kigawa J; Minagawa Y; Itamochi H; Sato S; Akeshima R; Terakawa N
    Eur J Surg Oncol; 2000 Aug; 26(5):464-7. PubMed ID: 11016467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
    Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
    Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
    Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early cervical cancer and parametrial involvement: is it significant?
    Steed H; Capstick V; Schepansky A; Honore L; Hiltz M; Faught W
    Gynecol Oncol; 2006 Oct; 103(1):53-7. PubMed ID: 16516279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolated full-thickness cervical stromal invasion warrants post-hysterectomy pelvic radiotherapy in FIGO stages IB-IIA uterine cervical carcinoma.
    Moon SH; Wu HG; Ha SW; Lee HP; Kang SB; Song YS; Park NH; Kim JW; Park IA; Kim BH
    Gynecol Oncol; 2007 Jan; 104(1):152-7. PubMed ID: 16935323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and clinical relevance of cyclooxygenase-1 and -2 expression in stage IIB cervical adenocarcinoma.
    Jung YW; Kim SW; Kim S; Kim JH; Cho NH; Kim JW; Kim YT
    Eur J Obstet Gynecol Reprod Biol; 2010 Jan; 148(1):62-6. PubMed ID: 19836124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
    Cheng XD; Lü WG; Ye F; Chen HZ; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-hysterectomy radiotherapy in FIGO stage IB-IIB uterine cervical carcinoma.
    Kim JH; Kim HJ; Hong S; Wu HG; Ha SW
    Gynecol Oncol; 2005 Feb; 96(2):407-14. PubMed ID: 15661229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemotherapy.
    Nagai N; Tian X; Mukai K; Hirata E; Kusuda T; Shiroyama Y; Shigemasa K; Ohama K
    Int J Mol Med; 2003 Nov; 12(5):709-14. PubMed ID: 14532998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of HuR is associated with increased cyclooxygenase-2 expression in uterine cervical carcinoma.
    Lim SJ; Kim HJ; Kim JY; Park K; Lee CM
    Int J Gynecol Pathol; 2007 Jul; 26(3):229-34. PubMed ID: 17581403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of angiogenesis and recurrence-free survival of early stage cervical cancer patients undergoing radical hysterectomy with pelvic lymph node dissection.
    Phoophitphong T; Hanprasertpong J; Dechsukhum C; Geater A
    J Obstet Gynaecol Res; 2007 Dec; 33(6):840-8. PubMed ID: 18001452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes and prognostic factors of node-negative cervical cancer patients with deep stromal invasion or lymphovascular space involvement following radical hysterectomy.
    Suprasert P; Srisomboon J; Siriaunkgul S; Khunamornpong S; Phongnarisorn C; Siriaree S; Charoenkwan K; Cheewakriangkrai C; Kietpeerakool C
    J Med Assoc Thai; 2006 Sep; 89(9):1368-75. PubMed ID: 17100371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
    Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
    Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between cyclooxygenase-2 and matrix metalloproteinase-2 expression in non-small cell lung cancer.
    Byun JH; Lee MA; Roh SY; Shim BY; Hong SH; Ko YH; Ko SJ; Woo IS; Kang JH; Hong YS; Lee KS; Lee AW; Park GS; Lee KY
    Jpn J Clin Oncol; 2006 May; 36(5):263-8. PubMed ID: 16735371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.